CALR and neoplasm: One such strategy involves tumor-derived stanniocalcin-1 (STC1) interacting with calreticulin (CRT), one of the best identified damage-associated molecular patterns (DAMPS), which takes part in dead tumor cell removal because it can act as a “receptor”.